These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 12789687

  • 1. Cholecystokinin antagonists: pharmacological and therapeutic potential.
    Herranz R.
    Med Res Rev; 2003 Sep; 23(5):559-605. PubMed ID: 12789687
    [Abstract] [Full Text] [Related]

  • 2. Peptide/benzodiazepine hybrids as ligands of CCK(A) and CCK(B) receptors.
    Escherich A, Lutz J, Escrieut C, Fourmy D, van Neuren AS, Müller G, Schafferhans A, Klebe G, Moroder L.
    Biopolymers; 2003 Sep; 56(2):55-76. PubMed ID: 11592053
    [Abstract] [Full Text] [Related]

  • 3. The CCK(-like) receptor in the animal kingdom: functions, evolution and structures.
    Staljanssens D, Azari EK, Christiaens O, Beaufays J, Lins L, Van Camp J, Smagghe G.
    Peptides; 2011 Mar; 32(3):607-19. PubMed ID: 21167241
    [Abstract] [Full Text] [Related]

  • 4. [Cholecystokinins and their receptors. Functional aspects].
    Böhme GA, Blanchard JC.
    Therapie; 1992 Nov; 47(6):541-8. PubMed ID: 1301646
    [Abstract] [Full Text] [Related]

  • 5. [Advances in gastrointestinal hormones: cholecystokinin].
    Ubilluz R.
    Rev Gastroenterol Peru; 1994 Nov; 14(3):222-32. PubMed ID: 8000026
    [Abstract] [Full Text] [Related]

  • 6. Cholecystokinin and learning and memory processes.
    Hadjiivanova C, Belcheva S, Belcheva I.
    Acta Physiol Pharmacol Bulg; 2003 Nov; 27(2-3):83-8. PubMed ID: 14570153
    [Abstract] [Full Text] [Related]

  • 7. Cholecystokinin and panic disorder: past and future clinical research strategies.
    Bradwejn J, Koszycki D.
    Scand J Clin Lab Invest Suppl; 2001 Nov; 234():19-27. PubMed ID: 11713976
    [Abstract] [Full Text] [Related]

  • 8. Neurobiology of cholecystokinin.
    Moran TH, Schwartz GJ.
    Crit Rev Neurobiol; 1994 Nov; 9(1):1-28. PubMed ID: 8828002
    [Abstract] [Full Text] [Related]

  • 9. Role of cholecystokinin in appetite control and body weight regulation.
    Little TJ, Horowitz M, Feinle-Bisset C.
    Obes Rev; 2005 Nov; 6(4):297-306. PubMed ID: 16246215
    [Abstract] [Full Text] [Related]

  • 10. Integrated actions of cholecystokinin on the gastrointestinal tract: use of the cholecystokinin bioassay.
    Liddle RA.
    Gastroenterol Clin North Am; 1989 Dec; 18(4):735-56. PubMed ID: 2482253
    [Abstract] [Full Text] [Related]

  • 11. CCK1 antagonists: are they ready for clinical use?
    Peter SA, D'Amato M, Beglinger C.
    Dig Dis; 2006 Dec; 24(1-2):70-82. PubMed ID: 16699265
    [Abstract] [Full Text] [Related]

  • 12. CCKB/gastrin receptor antagonists: recent advances and potential uses in gastric secretory disorders.
    Jensen RT.
    Yale J Biol Med; 1996 Dec; 69(3):245-59. PubMed ID: 9165693
    [Abstract] [Full Text] [Related]

  • 13. [Structure-activity relationship of cystokinins: analogs exhibiting selective activity].
    Martinez J, Rodriguez M, Lignon MF, Galas MC, Amblard M, Rolland M, Mendre C, Fulcrand P, Laur J, Bernad N.
    J Pharm Belg; 1991 Dec; 46(1):9-16. PubMed ID: 2051303
    [Abstract] [Full Text] [Related]

  • 14. [Applicability of CCK receptor antagonists in physiologic and therapeutic studies].
    Heintges T, Niederau C.
    Z Gastroenterol; 1992 May; 30(5):337-43. PubMed ID: 1632116
    [Abstract] [Full Text] [Related]

  • 15. Conformationally constrained CCK8 analogues obtained from a rationally designed peptide library as ligands for cholecystokinin type B receptor.
    De Luca S, Saviano M, Della Moglie R, Digilio G, Bracco C, Aloj L, Tarallo L, Pedone C, Morelli G.
    ChemMedChem; 2006 Sep; 1(9):997-1006. PubMed ID: 16915602
    [Abstract] [Full Text] [Related]

  • 16. Key differences in molecular complexes of the cholecystokinin receptor with structurally related peptide agonist, partial agonist, and antagonist.
    Arlander SJ, Dong M, Ding XQ, Pinon DI, Miller LJ.
    Mol Pharmacol; 2004 Sep; 66(3):545-52. PubMed ID: 15322246
    [Abstract] [Full Text] [Related]

  • 17. Effect of CCK and its antagonists on gastric emptying.
    Scarpignato C, Varga G, Corradi C.
    J Physiol Paris; 1993 Sep; 87(5):291-300. PubMed ID: 8298606
    [Abstract] [Full Text] [Related]

  • 18. Clinical endocrinology and metabolism. Cholecystokinin.
    Rehfeld JF.
    Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):569-86. PubMed ID: 15533776
    [Abstract] [Full Text] [Related]

  • 19. Gastrin and cholecystokinin of the bullfrog, Rana catesbeiana, have distinct effects on gallbladder motility and gastric acid secretion in vitro.
    Nielsen KG, Bomgren P, Holmgren S, Johnsen AH.
    Gen Comp Endocrinol; 1998 Nov; 112(2):247-54. PubMed ID: 9784308
    [Abstract] [Full Text] [Related]

  • 20. [Receptors for cholecystokinin and gastrin].
    de Weerth A, Bläker M, von Schrenck T.
    Z Gastroenterol; 1999 May; 37(5):389-401. PubMed ID: 10413847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.